Abstract
Executive Summary
This report reviews, analyzes and sizes the cell based screening and analysis
market. The study uncovers interesting information about key equipment,
consumables, reagents, software and services that are marketed to biotech and
pharmaceutical companies that are doing drug discovery research.
Large bio-pharma companies have commented at industry meetings that fifty
percent of their high throughput compound screening projects in drug discovery
involves screening cells. The companies are using cell-based assays for both
primary and secondary screening and have taken a great interest in the areas
of high content screening and high content analysis.
The report assesses the market and maps the competitors on the market
landscape with more than 80 companies identified. The financial section sizes
the market and discusses the five-year revenue projection. The market is
segmented by major product areas as well as market sub segments. This market
is also segmented by major world regions to see the growth or how the market
share might change.
Major company alliances, M&As, patents that were issued during the last two
years are reviewed and analyzed. Large data tables summarize the alliances,
M&As and patents. The alliance table summarizes more than 210 deals. The
patent table displays key details of over 340 patents. This research report is
designed for people that include marketers, business development, top
executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc.
More than 42 detailed tables or figures provide key data about items such as
strategic alliances, M&As, market size, segments and the like.
This report includes 28 company profiles that provide the reader a snapshot of
the companies- focus or activities. The provided Internet links help readers
access companies' own web sites for further review.
| 
View Cart
